STAT Plus: For CRISPR enzymes, the gold rush is on
NIKOLAY DOYCHINOV/AFP/GETTY IMAGES
Jennifer Doudna and her colleagues have found a different CRISPR protein with properties that could make it a workhorse of therapeutic editing.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario